クイック注文

CD155 / PVR 抗体, マウスモノクローナル抗体

データシートレビュープロトコル
製品の説明: Active  
発現宿主: Human Cells  
  • Slide 1
10109-H08H-50
10109-H08H-100
50 µg 
100 µg 
Add to Cart
製品の説明: Active  
発現宿主: Human Cells  
  • Slide 1
10109-H02H-50
10109-H02H-100
50 µg 
100 µg 
Add to Cart
製品の説明: Active  
発現宿主: Human Cells  
  • Slide 1
50259-M03H-50
50259-M03H-100
50 µg 
100 µg 
Add to Cart
製品の説明: Active  
発現宿主: Human Cells  
  • Slide 1
50259-M08H-50
50259-M08H-100
50 µg 
100 µg 
Add to Cart
製品の説明: Active  
発現宿主: Human Cells  
  • Slide 1
80007-R08H-20
80007-R08H-100
20 µg 
100 µg 
Add to Cart
製品の説明: Active  
発現宿主: Human Cells  
  • Slide 1
90005-C08H-50
90005-C08H-20
50 µg 
20 µg 
Add to Cart

HP100017 

CD155/PVR AntibodyRelated Products

Related Products

Featured Reagent Products

CD155/PVR antibody 背景

CD155, commonly known as PVR (poliovirus receptor) and Necl-5 (nectin-like molecule-5), is a type I transmembrane single-span glycoprotein, and belongs to the nectins and nectin-like (Necl) subfamily. CD155 was originally identified based on its ability to mediate the cell attachment and entry of poliovirus (PV), an etiologic agent of the central nervous system disease poliomyelitis. The normal cellular function is in the establishment of intercellular adherens junctions between epithelial cells. CD155 may assist in an efficient humoral immune response generated within the intestinal immune system. It has been demonstrated that CD155 can be recognized and bond by DNAM-1 and CD96 which promote the adhension, migration and NK-cell killing, and thus efficiently prime cell-mediated tumor-specific immunity.

Immune Checkpoint
Immune Checkpoint Detection: ELISA Antibodies   Immune Checkpoint Detection: ICC Antibodies   Immune Checkpoint Detection: IP Antibodies   Immune Checkpoint Detection: FCM Antibodies   Immune Checkpoint Detection: WB Antibodies
Immune Checkpoint Proteins
Immune Checkpoint Targets   Co-inhibitory Immune Checkpoint Targets

Immunotherapy   Cancer Immunotherapy   Targeted Therapy

人々 CD155/PVR antibody 参考文献
  • Freistadt MS, et al. (2000) Hematopoietic cells from CD155-transgenic mice express CD155 and support poliovirus replication ex vivo. Microb Pathog. 29(4): 203-12.
  • Sato T, et al. (2004) Involvement of heterophilic trans-interaction of Necl-5/Tage4/PVR/CD155 with nectin-3 in formation of nectin- and cadherin-based adherens junctions. Genes Cells. 9(9): 791-9.
  • Kakunaga S, et al. (2004) Enhancement of serum- and platelet-derived growth factor-induced cell proliferation by Necl-5/Tage4/poliovirus receptor/CD155 through the Ras-Raf-MEK-ERK signaling. J Biol Chem. 279(35): 36419-25.
  • Sato T, et al. (2005) Common signaling pathway is used by the trans-interaction of Necl-5/Tage4/PVR/CD155 and nectin, and of nectin and nectin during the formation of cell-cell adhesion. Cancer Sci. 96(9): 578-89.
  • Minami Y, et al. (2007) Involvement of up-regulated Necl-5/Tage4/PVR/CD155 in the loss of contact inhibition in transformed NIH3T3 cells. Biochem Biophys Res Commun. 352(4): 856-60.
  • 注意:すべての製品は、"研究目的のみに使用するものであり、診断または治療目的に使用するものではありません"